Outset Medical, Inc. Selling and Marketing Expense
Outset Medical, Inc. (OM) reported Selling and Marketing Expense of $12.15 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-06
- Outset Medical, Inc. selling and marketing expense for the quarter ending 2026-06-30 was $12.15M, a 14.90% decline year-over-year.
- Outset Medical, Inc. selling and marketing expense for the quarter ending 2026-03-31 was $13.28M, a 2.73% decline year-over-year.
- Outset Medical, Inc. selling and marketing expense for the quarter ending 2025-12-31 was $12.88M, a 16.65% decline year-over-year.
- Outset Medical, Inc. selling and marketing expense for the quarter ending 2025-09-30 was $13.55M, a 12.11% decline year-over-year.
- Outset Medical, Inc. selling and marketing expense for fiscal 2025 was $54.36M, a 22.39% decline from fiscal 2024.
- Outset Medical, Inc. selling and marketing expense for fiscal 2024 was $70.04M, a 27.21% decline from fiscal 2023.
- Outset Medical, Inc. selling and marketing expense for fiscal 2023 was $96.23M, a 7.54% increase from fiscal 2022.
- Outset Medical, Inc. selling and marketing expense for fiscal 2022 was $89.48M, a 37.52% increase from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $12.15M 10-Q · filed 2026-08-06 | $25.43M 10-Q · filed 2026-08-06 | $38.31M derived: sum of 3 quarters · filed 2026-08-06 | $51.86M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $13.28M 10-Q · filed 2026-05-07 | $26.16M derived: sum of 2 quarters · filed 2026-05-07 | $39.71M derived: sum of 3 quarters · filed 2026-05-07 | $53.99M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $12.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $26.43M derived: sum of 2 quarters · filed 2026-02-13 | $40.71M derived: sum of 3 quarters · filed 2026-08-06 | $54.36M 10-K · filed 2026-02-13 |
| 2025-09-30 | $13.55M 10-Q · filed 2025-11-10 | $27.83M derived: sum of 2 quarters · filed 2026-08-06 | $41.48M 10-Q · filed 2025-11-10 | $56.93M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $14.28M 10-Q · filed 2026-08-06 | $27.93M 10-Q · filed 2026-08-06 | $43.38M derived: sum of 3 quarters · filed 2026-08-06 | $58.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $13.65M 10-Q · filed 2026-05-07 | $29.10M derived: sum of 2 quarters · filed 2026-05-07 | $44.52M derived: sum of 3 quarters · filed 2026-05-07 | $62.65M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $15.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $30.87M derived: sum of 2 quarters · filed 2026-02-13 | $49.00M derived: sum of 3 quarters · filed 2026-02-13 | $70.04M 10-K · filed 2026-02-13 |
| 2024-09-30 | $15.42M 10-Q · filed 2025-11-10 | $33.55M derived: sum of 2 quarters · filed 2025-11-10 | $54.59M 10-Q · filed 2025-11-10 | $76.79M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $18.13M 10-Q · filed 2025-08-07 | $39.18M 10-Q · filed 2025-08-07 | $61.37M derived: sum of 3 quarters · filed 2026-02-13 | $86.09M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $21.05M 10-Q · filed 2025-05-08 | $43.24M derived: sum of 2 quarters · filed 2026-02-13 | $67.96M derived: sum of 3 quarters · filed 2026-02-13 | $92.95M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $22.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $46.91M derived: sum of 2 quarters · filed 2026-02-13 | $71.90M derived: sum of 3 quarters · filed 2026-02-13 | $96.23M 10-K · filed 2026-02-13 |
| 2023-09-30 | $24.72M 10-Q · filed 2024-11-07 | $49.70M derived: sum of 2 quarters · filed 2024-11-07 | $74.04M 10-Q · filed 2024-11-07 | $97.67M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $24.98M 10-Q · filed 2024-08-08 | $49.32M 10-Q · filed 2024-08-08 | $72.95M derived: sum of 3 quarters · filed 2025-02-28 | $95.22M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $24.33M 10-Q · filed 2024-05-09 | $47.96M derived: sum of 2 quarters · filed 2025-02-28 | $70.24M derived: sum of 3 quarters · filed 2025-02-28 | $93.44M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $23.63M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $45.91M derived: sum of 2 quarters · filed 2025-02-28 | $69.11M derived: sum of 3 quarters · filed 2025-02-28 | $89.48M 10-K · filed 2025-02-28 |
| 2022-09-30 | $22.28M 10-Q · filed 2023-11-08 | $45.47M derived: sum of 2 quarters · filed 2023-11-08 | $65.85M 10-Q · filed 2023-11-08 | $88.84M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $23.20M 10-Q · filed 2023-08-03 | $43.58M 10-Q · filed 2023-08-03 | $66.57M derived: sum of 3 quarters · filed 2024-02-21 | $82.29M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $20.38M 10-Q · filed 2023-05-04 | $43.37M derived: sum of 2 quarters · filed 2024-02-21 | $59.09M derived: sum of 3 quarters · filed 2024-02-21 | $72.30M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $22.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $38.72M derived: sum of 2 quarters · filed 2024-02-21 | $51.92M derived: sum of 3 quarters · filed 2024-02-21 | $65.07M 10-K · filed 2024-02-21 |
| 2021-09-30 | $15.73M 10-Q · filed 2022-11-09 | $28.93M derived: sum of 2 quarters · filed 2022-11-09 | $42.08M 10-Q · filed 2022-11-09 | $57.28M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-06-30 | $13.20M 10-Q · filed 2022-08-02 | $26.35M 10-Q · filed 2022-08-02 | $41.55M derived: sum of 3 quarters · filed 2023-02-13 | $54.90M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-03-31 | $13.15M 10-Q · filed 2022-05-05 | $28.35M derived: sum of 2 quarters · filed 2023-02-13 | $41.69M derived: sum of 3 quarters · filed 2023-02-13 | $50.94M derived: sum of 4 quarters · filed 2023-02-13 |
| 2020-12-31 | $15.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $28.54M derived: sum of 2 quarters · filed 2023-02-13 | $37.79M derived: sum of 3 quarters · filed 2023-02-13 | $45.07M 10-K · filed 2023-02-13 |
| 2020-09-30 | $13.34M 10-Q · filed 2021-11-04 | $22.59M derived: sum of 2 quarters · filed 2021-11-04 | $29.87M 10-Q · filed 2021-11-04 | $36.75M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $9.24M 10-Q · filed 2021-08-06 | $16.53M 10-Q · filed 2021-08-06 | $23.41M derived: sum of 3 quarters · filed 2022-02-23 | $28.42M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | $7.28M 10-Q · filed 2021-05-06 | $14.16M derived: sum of 2 quarters · filed 2022-02-23 | $19.17M derived: sum of 3 quarters · filed 2022-02-23 | |
| 2019-12-31 | $6.88M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $11.89M derived: sum of 2 quarters · filed 2022-02-23 | $20.26M 10-K · filed 2022-02-23 | |
| 2019-09-30 | $5.01M 10-Q · filed 2020-11-12 | $13.38M 10-Q · filed 2020-11-12 | ||
| 2018-12-31 | $11.28M 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |